Florence Myrick

机构：Gilead Sciences (United States)

发表论文 13 篇 · 总被引 657 次 · h-index 9

代表论文

• No Resistance to Tenofovir Disoproxil Fumarate Detected After up to 144 Weeks of Therapy in Patients Monoinfected With Chronic Hepatitis B Virus Δ (2010 · Hepatology · 被引 178)
• Design and Profiling of GS-9148, a Novel Nucleotide Analog Active against Nucleoside-Resistant Variants of Human Immunodeficiency Virus Type 1, and Its Orally Bioavailable Phosphonoamidate Prodrug, GS-9131 (2007 · Antimicrobial Agents and Chemotherapy · 被引 94)
• In Vitro Evaluation of the Anti-HIV Activity and Metabolic Interactions of Tenofovir and Emtricitabine (2006 · Antiviral Therapy · 被引 70)
• The A62V and S68G Mutations in HIV-1 Reverse Transcriptase Partially Restore the Replication Defect Associated With the K65R Mutation (2008 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 68)
• The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study (2009 · Retrovirology · 被引 66)
• Dioxolane Guanosine, the Active Form of the Prodrug Diaminopurine Dioxolane, Is a Potent Inhibitor of Drug-Resistant HIV-1 Isolates From Patients for Whom Standard Nucleoside Therapy Fails (2002 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 66)